Chinese Biotech Firm Leto Lab Secures RMB100 Million

Leto Lab, a biotechnology focused on recobinant protein drugs, has recently completed a series B financing of over RMB100 million yuan. This round of financing was jointly invested by Yijing Capital, Qiaojing Capital and Chang Development. Prior to this, Leto Lab has successively received investment from Sherpa Investment, Powerfang Capital, Qirong Venture Capital, Waige Capital […]

Chinese Biotech Firm Leto Lab Secures RMB100 Million comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.

Comments are closed.